Market Overview:
The global losartan and hydrochlorothiazide tablets market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of hypertension and rising awareness about the benefits of losartan and hydrochlorothiazide tablets. Based on type, the global losartan and hydrochlorothiazide tablets market is segmented into 50 mg/ 12.5 mg, 100 mg/ 25 mg, 200 mg/ 50mg, and others. The 100mg/ 25mg segment is expected to account for the largest share in terms of revenue in 2018 owing to its high efficacy in controlling blood pressure levels as compared to other dosage strengths available in the market. Based on application, hospitals are estimated to account for a major share of revenue generated by sales of losartan and hydrochlorothiazide tablets during 2018-2030 owing to their large patient population base suffering from hypertension across all regions covered in this study.
Product Definition:
Losartan and Hydrochlorothiazide Tablets are a combination medication used to treat high blood pressure. It works by decreasing the amount of water in the body, which helps to lower blood pressure.
50 mg/ 12.5 mg:
50 mg/12.5 mg Losartan tablets are used for the treatment of hypertension and to lower the risk of stroke and heart attack. It works by decreasing blood pressure through a reduction in peripheral resistance, which is an effect of antihypertensive drugs.
100 mg/ 25 mg:
100 mg/25 mg is used in Losartan and Hydrochlorothiazide tablets for the treatment of hypertension. The drug has a generic name, which is known by different brand names such as Acomplia, Cardiapres, Diurex, Myminox, Vascor among others. It’s an angiotensin II receptor blocker used to treat high blood pressure and congestive heart failure.
Application Insights:
The major application of Losartan and Hydrochlorothiazide Tablets includes hospital, clinics and recovery centers. The hospital segment dominated the market in 2017 due to high usage in the treatment of hypertension. Moreover, increasing number of product launches by different manufacturers is expected to boost industry growth over the forecast period. For instance, in January 2018 Teva Pharmaceuticals launched losartan potassium 50 mg/ 12.5 mg & hydrochlorothiazide 25 mg tablets for hypertension under the brand name Cartia XT generic version across various countries worldwide (excluding U.S., Canada and Japan).
The clinics segment is expected to witness significant growth during the forecast period as a result of rising awareness about alternative treatments for chronic diseases such as heart disease along with an increase in patient visits due to high prevalence of target diseases globally such as diabetes & heart conditions among other reasons including lifestyle disorders like smoking etcetera worldwide during recent years which will drive demand for Losartan.
Regional Analysis:
North America was the largest market for Losartan and Hydrochlorothiazide Tablets, accounting for more than 50% of global revenue in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to rising incidence of hypertension coupled with growing awareness about product benefits among patients in this region. In addition, presence of key manufacturers such as Cipla Inc.; Mylan N.V.; Actavis plc; and Teva Pharmaceuticals USA, Inc.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to increasing geriatric population suffering from kidney diseases & Hypertension coupled with growing medical tourism industry in emerging economies such as India & China which will boost demand for Losartan.
Growth Factors:
- Increasing prevalence of hypertension and other cardiovascular diseases: The global prevalence of hypertension is estimated to be around 1.13 billion in 2015 and is projected to reach 1.56 billion by 2025. This will create a large pool of patients who will require treatment, thereby driving the demand for losartan and hydrochlorothiazide tablets market.
- Rising geriatric population: The number of people aged 60 years or above is increasing rapidly across the world due to improved healthcare facilities and longer life expectancies. This growing population is more susceptible to developing hypertension, which in turn will fuel the demand for losartan and hydrochlorothiazide tablets market over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Losartan and Hydrochlorothiazide Tablets Market Research Report
By Type
50 mg/ 12.5 mg, 100 mg/ 25 mg
By Application
Hospital, Clinics, Recovery Center
By Companies
Alembic, Cadista, Lupin, Rising Pharmaceuticals, Sandoz, Teva, Merck, Torrent, Aurobindo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Losartan and Hydrochlorothiazide Tablets Market Report Segments:
The global Losartan and Hydrochlorothiazide Tablets market is segmented on the basis of:
Types
50 mg/ 12.5 mg, 100 mg/ 25 mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alembic
- Cadista
- Lupin
- Rising Pharmaceuticals
- Sandoz
- Teva
- Merck
- Torrent
- Aurobindo
Highlights of The Losartan and Hydrochlorothiazide Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 50 mg/ 12.5 mg
- 100 mg/ 25 mg
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Losartan and Hydrochlorothiazide Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Losartan and Hydrochlorothiazide Tablets are medications used to treat high blood pressure. They work by decreasing the amount of blood that flows through your veins. This can lower your blood pressure enough to help prevent heart problems.
Some of the major players in the losartan and hydrochlorothiazide tablets market are Alembic, Cadista, Lupin, Rising Pharmaceuticals, Sandoz, Teva, Merck, Torrent, Aurobindo.
The losartan and hydrochlorothiazide tablets market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Losartan and Hydrochlorothiazide Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Losartan and Hydrochlorothiazide Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Losartan and Hydrochlorothiazide Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Losartan and Hydrochlorothiazide Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Losartan and Hydrochlorothiazide Tablets Market Size & Forecast, 2020-2028
4.5.1 Losartan and Hydrochlorothiazide Tablets Market Size and Y-o-Y Growth
4.5.2 Losartan and Hydrochlorothiazide Tablets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 50 mg/ 12.5 mg
5.2.2 100 mg/ 25 mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Losartan and Hydrochlorothiazide Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Losartan and Hydrochlorothiazide Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 50 mg/ 12.5 mg
9.6.2 100 mg/ 25 mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 50 mg/ 12.5 mg
10.6.2 100 mg/ 25 mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 50 mg/ 12.5 mg
11.6.2 100 mg/ 25 mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 50 mg/ 12.5 mg
12.6.2 100 mg/ 25 mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 50 mg/ 12.5 mg
13.6.2 100 mg/ 25 mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Losartan and Hydrochlorothiazide Tablets Market: Competitive Dashboard
14.2 Global Losartan and Hydrochlorothiazide Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alembic
14.3.2 Cadista
14.3.3 Lupin
14.3.4 Rising Pharmaceuticals
14.3.5 Sandoz
14.3.6 Teva
14.3.7 Merck
14.3.8 Torrent
14.3.9 Aurobindo
